Fortis Hospital Nagarbhavi launches State-of-the-Art AZURION 7C12 Cath Lab

Bengaluru, 18 January 2023: Fortis Hospital, Nagarbhavi today launched an advanced State-of the-Art Philips Azurion7 C12 Cath Lab facility for faster and timely diagnosis and treatment related to interventional cardiology and cardiovascular surgeries. The state-of-the-art Cath Lab was inaugurated by Shri. C. N. Ashwath Narayan (Honourable Minister of Skill Development, Entrepreneurship and Livelihood of Karnataka)along withShri. M Mahadevaiah (District & Session Judge and Head of Legal Cell)in the presence of Dr Vivek Jawali (Chairman- Cardiac Sciences, Fortis Hospitals, Bengaluru), Dr. C PrabhakarKoregol (Senior Consultant - Interventional Cardiology, Fortis Hospital, Nagarbhavi) and Mr. Akshay Oleti (Business Head, Fortis Hospitals, Bengaluru). 

The high-end version of Philips AZURION 7C12 Monoplane Cath Lab has cutting-edge technologies with an integrated Instantaneous Wave-Free Ratio-IFR (a trans-lesion pressure ratio measured during the wave-free period reducing the risk of Hyperemia agents). It also has a unique advanced interventional tool like DYNAMIC CORONARY ROADMAP (DCR), which creates a dynamic, motion-compensated, real time view of the coronary arteries which automatically adjusts on 2D fluoroscopy, providing continuous and specific visual feedback on positioning of wires, catheters and devices during Percutaneous Coronary Intervention, hence reducing contact with patients. The Cath Lab will also provide patients with enhanced care, accurate interventions, effective treatment alternatives and minimal radiation exposure.  

Speaking on the occasion, Shri. C. N. Ashwath Narayan, Honourable Minister of Skill Development, Entrepreneurship and Livelihood of Karnatakasaid, “I congratulate Fortis Hospital, Nagarbhavi and the cardiac team on the launch. The consistent efforts by Fortis to provide patients with latest treatment modalities will help boost cardiac related healthcare. I extend my gratitude and wish Fortis Hospitals the very best for their commitment to patient care.” 

Shri. M Mahadevaiah, District & Session Judge and Head of Legal Cell, said, "Healthcare enabled technology has been revolutionizing the way patients are being treated. Such advanced technological innovations will go a long way by reducing cardiac related deaths. I would like to commend the efforts

of the cardiac team for their dedication to providing the best care for patients. I wish Fortis Nagarbhavi all the best for their future endeavors." 

Speaking on the launch, Dr. C PrabhakarKoregol, Senior Consultant - Interventional Cardiology, Fortis Hospital, Nagarbhavi said, “The necessity for emergency cardiac treatment is on the rise, due to the complexity of patient profiles and changing disease patterns. Thus, we need to be technologically equipped to be able to treat the patients more efficiently and save lives. Our state-of-the-art Azurion Cath Lab is equipped with unique advanced tools that will facilitate fast and accurate interventions in structural heart diseases. Thus, it provides an advantage for surgeons to offer advanced cardiac interventions in minimal time with greater precision and better clinical outcomes.”  

Mr. Akshay Oleti, Business Head, Fortis Hospitals, Bengaluru said, “Fortis Hospitals has always been on the forefront of providing cutting edge treatment to our patients. With the launch of state-of-the-art Cath Lab at Fortis Nagarbhavi, the hospital will now be setting a new benchmark in the adoption of high-end technology for patient care. We are hopeful that the advanced Cath lab will help our doctors at the facility to successfully tackle complex procedures while improving clinical outcomes and enriching overall patient experience.” 

About Fortis Healthcare Limited

Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with 27 healthcare facilities, 4,300 operational beds and 419 diagnostics centers (including JVs). Fortis is present in India, United Arab Emirates (UAE), Nepal & Sri Lanka. The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with global major and parent company - IHH, to build upon its culture of world-class patient care and superlative clinical excellence. Fortis employs ~23,000 people (including SRL) who share its vision of becoming the world’s most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.